Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

The generative AI revolution faces a multi-trillion-dollar challenge: the soaring cost of inference, or running AI models.

When it comes to working with data in a tabular form, most people reach for a spreadsheet. That’s not a bad choice: Microsoft Excel and similar programs are familiar and loaded with functionality for ...

In the dynamic environment of small to medium enterprises and startups, leaders often face a barrage of tasks demanding immediate attention. The Eisenhower Matrix, a strategic prioritization tool, ...